The estimated Net Worth of Glenn David is at least 18.7 百万$ dollars as of 23 February 2022. Mr. David owns over 32,390 units of Zoetis Inc stock worth over 15,001,990$ and over the last 10 years he sold ZTS stock worth over 0$. In addition, he makes 3,672,350$ as Chief Financial Officer、 Executive Vice President at Zoetis Inc.
Sign up
Mr. David ZTS stock SEC Form 4 insiders trading
Glenn has made over 11 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 32,390 units of ZTS stock worth 2,515,084$ on 23 February 2022.
The largest trade he's ever made was exercising 43,778 units of Zoetis Inc stock on 5 March 2020 worth over 2,355,256$. On average, Glenn trades about 3,618 units every 21 days since 2014. As of 23 February 2022 he still owns at least 78,962 units of Zoetis Inc stock.
You can see the complete history of Mr. David stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Glenn David biography
Glenn C. David serves as Chief Financial Officer, Executive Vice President of the Company. Mr. David has served as our Executive Vice President and Chief Financial Officer since August 2016. With more than 25 years of experience in finance and operations, Mr. David has played a key role in leading the financial operations for Zoetis since its initial public offering in 2013. He served as our Senior Vice President of Finance Operations from 2013 to 2016 and as acting Chief Financial Officer from April 2014 through August 2014. Mr. David joined Pfizer in 1999 and held various financial roles, including Vice President of Global Finance for Pfizer Animal Health, our predecessor company, and Vice President of Finance for the U.S. Primary Care franchise.
What is the salary of Glenn David?
As the Chief Financial Officer、 Executive Vice President of Zoetis Inc, the total compensation of Glenn David at Zoetis Inc is 3,672,350$. There are no executives at Zoetis Inc getting paid more.
How old is Glenn David?
Glenn David is 48, he's been the Chief Financial Officer、 Executive Vice President of Zoetis Inc since 2016. There are 21 older and 1 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
What's Glenn David's mailing address?
Glenn's mailing address filed with the SEC is 300 FRANK W. BURR BLVD.,, STE 21, TEANECK, NJ, 07666.
Insiders trading at Zoetis Inc
Over the last 12 years, insiders at Zoetis Inc have traded over 876,669,659$ worth of Zoetis Inc stock and bought 1,602,140 units worth 77,083,975$ . The most active insiders traders include Square Capital Management, ...、Frank A Damelio、Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of 14,414,921$. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth 170,041$.
What does Zoetis Inc do?
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
What does Zoetis Inc's logo look like?
Complete history of Mr. David stock trades at Phibro Animal Health、Zoetis Inc
Zoetis Inc executives and stock owners
Zoetis Inc executives and other stock owners filed with the SEC include:
-
Glenn David,
Chief Financial Officer, Executive Vice President -
Kristin Peck,
Chief Executive Officer, Director -
Catherine Knupp,
Executive Vice President, President - Research and Development -
Kristin C. Peck,
CEO & Director -
Wafaa Mamilli,
Exec. VP and Chief Information & Digital Officer -
Roman Trawicki,
Exec. VP and Pres of Global Manufacturing & Supply -
Glenn C. David,
Exec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance -
Michael McCallister,
Non-Executive Independent Chairman of the Board -
Robert Scully,
Independent Director -
Gregory Norden,
Independent Director -
Paul Bisaro,
Independent Director -
William Steere,
Independent Director -
Linda Rhodes,
Independent Director -
Willie Reed,
Independent Director -
Louise Parent,
Independent Director -
Sanjay Khosla,
Independent Director -
Frank D'Amelio,
Independent Director -
Roman Trawicki,
Executive Vice President, President - Global Manufacturing and Supply -
Heidi Chen,
Executive Vice President, General Counsel, Corporate Secretary -
Roxanne Lagano,
Chief Human Resource Officer, Executive Vice President and Global Operations -
Heidi C. Chen,
Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics -
Roxanne Lagano,
Exec. VP and Chief HR Officer & Global Operations -
Wetteny N. Joseph,
Exec. VP & CFO -
Timothy J. Bettington,
Exec. VP and Pres of U.S. Operations & Global Customer Experience -
William Price,
VP & Chief Communications Officer -
Steven Frank,
VP of Investor Relations -
Gavin Hattersley,
Director -
Robert Edward Kelly,
Executive Vice President -
Alejandro Bernal,
Executive Vice President -
Juan Ramon Alaix,
Director -
Clinton A. Jr. Lewis,
Executive Vice President -
Sherry N Pudloski,
Executive Vice President -
Robert J Polzer,
Executive Vice President -
Amy W Schulman,
Director -
Sandra J. Beaty,
Executive Vice President -
Joyce J. Lee,
Executive Vice President -
Douglas E. Giordano,
Director -
William F Doyle,
-
Inc Pfizer,
Director -
Square Capital Management, ...,
-
Stefan Weiskopf,
Executive Vice President -
Richard A. Passov,
EVP, Chief Financial Officer -
Paul Herendeen,
Exec. V.P. and CFO -
Charles H Hill,
Director -
Geno J Germano,
Director -
Andrew Fenton,
Executive Vice President -
James Michael Mc Farland,
Executive Vice President -
Wafaa Mamilli,
Executive Vice President -
Timothy J Bettington,
Executive Vice President -
Antoinette Renee Leatherberry,
Director -
Astorga Jeannette Ferran,
Executive Vice President -
Abhay U Nayak,
Executive Vice President -
Wetteny Joseph,
Chief Financial Officer -
Rimma Driscoll,
Executive Vice President -
Vanessa Broadhurst,
Director -
Jamie Brannan,
Executive Vice President -
Nicholas Ashton,
Executive Vice President -
Soria Ester Banque,
Executive Vice President